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Abstract: Salmonella species are frequently associated with gastrointestinal infections such as 
diarrhea. However, extraintestinal Salmonella infections, including burn infections, have been 
described. Here, we report the first case of a carbapenem-resistant and metallo-β-lactamase (New 
Delhi metallo-β-lactamase), extended-spectrum β-lactamase (SHV-12), and AmpC β-lactamase 
(CMY-4) coproducing Salmonella Typhimurium isolated from a fatal case of burn wound infec-
tion. The publication highlights the necessity for the rational use of antibiotics (particularly the 
rational use of last-resort antibiotics such as carbapenems) in hospitals and burn units, as well 
as the need for systematic screening of Salmonella spp. (including Salmonella enterica serovar 
Typhimurium) for resistance to carbapenem antibiotics.
Keywords: Salmonella, metallo-β-lactamase, extended-spectrum and AmpC β-lactamase, 
coproduction, whole genome sequencing, fatal burn wound
Introduction
Salmonella species are commonly associated with gastrointestinal infections, although 
extraintestinal Salmonella infections involving sepsis, liver abscesses, surgical wounds, 
joint infections, and infected burn wounds have been described.1 Particularly important 
with respect to the treatment of wounds from severe burns is the application of immedi-
ate specialized and effective care, which includes antimicrobial therapy, to minimize 
morbidity and mortality.2 Both intestinal and extraintestinal Salmonella infections are 
often treated with cephalosporins and quinolones, although the bacterium is becoming 
increasingly resistant to these antibiotics. On the other hand, carbapenem resistance 
in Salmonella is rarely reported3 – even though resistance to carbapenem antibiotics 
continues to be a major public health concern in other pathogens like Pseudomonas 
aeruginosa and Acinetobacter baumannii.4 Importantly, carbapenem antibiotics are 
considered “last-resort” antibiotics for use in the treatment of infections caused by 
multidrug-resistant isolates of bacteria.5 Associated with carbapenem resistance are 
several carbapenemase enzymes, including New Delhi metallo-β-lactamase (NDM-1) 
and its variants, which hydrolyze a wide range of β-lactam antibiotics.6 Other nonhy-
drolyzing mechanisms associated with carbapenem resistance in pathogenic bacteria 
include enhanced removal of antibiotic via an increase in bacterial efflux pump activ-
ity and mutations in bacterial cell envelope porin genes, which hinder the uptake of 
carbapenem antibiotics into the bacterial cell.7
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Case report
In this report, the authors report on the first case of a 
Salmonella enterica serovar Typhimurium isolate that is 
carbapenem-resistant, NDM-1-positive, extended-spectrum 
β-lactamase (SHV-12)-positive, and AmpC β-lactamase 
(CMY-4)-producing. This strain was isolated from a fatal 
case following a burn wound infection. To the best of our 
knowledge, this is the first reported case of a fatal burn wound 
infection associated with a NDM-1 carbapenem-resistant 
(multidrug-resistant) S. enterica serovar Typhimurium.
A 17-year-old male patient with 70% burns was admit-
ted to a private nursing home in Kolkata, India, in 2016. 
All methods were carried out in accordance with relevant 
guidelines and regulations. The microbial isolate mentioned 
in this case report was cultured from sample collected during 
routine care and diagnostic investigations. The single patient 
was not specifically sampled for this study, and the subject 
from whom it was isolated deceased after collection of first 
sample. Culture of the burn wound at the Drs Tribedi and 
Roy Diagnostic Laboratory, Kolkata, revealed the presence 
of Salmonella. Stool and blood samples were not available 
for laboratory diagnosis as the patient had unfortunately 
passed away by the time the laboratory report was received 
by the private nursing home. The cultured Salmonella spp. 
isolate was initially identified biochemically using bioMéri-
eux VITEK® 2 compact system (bioMérieux, Inc., Durham, 
NC, USA), followed by confirmation using specific antisera 
(Murex Biotech, Dartford, England). Serovar determination 
was performed at the Central Research Institute, Kasauli, 
India, according to the Kauffmann–White scheme.
Antibiotic susceptibility testing by disc diffusion 
( antibiotic discs purchased from HiMedia Laboratories 
Ltd, Mumbai, India) and the bioMérieux Vitek® 2 compact 
 system (as per CLSI, 2014) revealed that the isolate was only 
susceptible to colistin, tigecycline, and polymyxin B. This 
isolate was resistant to the following antibiotics: ampicillin, 
cefoxitin, ceftriaxone, cefotaxime, ceftazidime, cefepime, 
aztreonam, ciprofloxacin, nalidixic acid, levofloxacin, mino-
cycline (tetracycline), cefoperazone–sulbactam, piperacil-
lin–tazobactam, meropenem, imipenem, chloramphenicol, 
gentamicin, amikacin, tobramycin, and chloramphenicol. 
Minimum inhibitory concentrations (MICs) of various anti-
biotics against Salmonella Typhimurium as determined by 
the bioMérieux Vitek® 2 compact system are listed in Table 1.
Modified Hodge test for the detection of carbapenemase 
was negative. However, metallo-β-lactamase (MBL) activity 
was detected using the double disc synergy test using imipe-
nem and imipenem-EDTA discs (HiMedia Laboratories Ltd). 
But, repeated disc diffusion testing of the Salmonella isolate 
after 1 week of storage indicated that the isolate had become 
susceptible to meropenem, which suggested the potential 
involvement of bacterial outer membrane proteins (porins 
and efflux pumps) in the carbapenem-resistant phenotype.8
The isolate was positive for bla
NDM
 by multiplex PCR tar-
geting bla
NDM
, bla
OXA-48
, bla
VIM
, bla
IMP
, and bla
KPC
.18 PCRs target-
ing five bla
CTX-M
 groups and AmpC β lactamase genes were also 
performed. The isolate was negative for all bla
CTX-M
 groups, but 
positive for the CIT Group type of AmpC β-lactamases (primer 
sequences [Synergy Scientific Services, Chennai, India] as per 
Table 219 and Pérez-Pérez and Hanson20).
Plasmid-based replicon typing indicated that the isolate 
possessed an FIB replicon type plasmid. In order to investi-
gate the possibility of horizontal transfer of plasmid(s) bear-
ing bla
NDM
 and AmpC β-lactamase CIT, a conjugation assay 
was performed using the clinical Salmonella Typhimurium 
isolate as donor and a sodium azide resistant E. coli J53 as 
Table 1 MICs of antibiotics against Salmonella typhimurium as determined by the bioMérieux Vitek® 2 compact system
Sl 
no
Antibiotic MIC (μg/mL) interpretive 
criteria for resistancea
MIC (μg/mL) of antibiotics against 
the test isolate
Interpretation
1 piperacillin–tazobactam ≥128/4b ≥128/4b Resistant
2 Ceftazidime ≥16 ≥64 Resistant
3 Cefepime ≥16 ≥64 Resistant
4 aztreonam ≥16 ≥64 Resistant
5 Imipenem ≥4 ≥16 Resistant
6 Meropenem ≥4 ≥16 Resistant
7 amikacin ≥64 ≥64 Resistant
8 Gentamicin ≥16 ≥16 Resistant
9 Ciprofloxacin ≥1 ≥4 Resistant
10 Levofloxacin ≥2 ≥8 Resistant
Notes: aMIC interpretive criteria for resistance to antibiotics based on CLsI 2014 guidelines. bDenotes values for 2 antibiotics together.
Abbreviations: MIC, minimum inhibitory concentration; sl no, serial number.
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Table 2 PCR primer sequences used to confirm the presence/
absence of CtX-M esBL-encoding resistance genes
Target 
gene
Primer sequence 5′–3′ Amplicon 
size (bp)
blaCtX-M grp 1 F: aaaaatCaCtGCGCCaGttC
R: aGCttattCatCGCCaCGtt
415 
blaCtX-M grp 2 F: CGaCGCtaCCCCtGCtatt
R: CCaGCGtCaGatttttCaGG
552 
blaCtX-M grp 8 F: tCGCGttaaGCGGatGat GC
R: aaCCCaCGatGtGGGtaC
666 
blaCtX-M grp 9 F: CaaaGaGaGtGCaaCGGa tG
R:attGGaaaGCGttCatCaCC
205 
blaCtX-M grp 25 F: GCaCGatGaCattCGGG
R: aaCCCaCGatGtGGGtaGC
327 
Note: Data adapted from Woodford et al.19
Abbreviations: esBL, extended-spectrum β-lactamase; F, sense primer; R, 
antisense primer.
recipient bacteria. The transconjugants were found to be 
resistant to cefotaxime and cefoxitin, but sensitive to imipe-
nem. The transconjugates showed a 4 log decrease in MIC to 
cefotaxime, but were still classified as cefotaxime resistant, 
indicating that resistance to cefotaxime was not only plasmid 
mediated, but may also be due to additional mechanisms such 
as efflux pumps or loss of outer membrane porins. However, 
an efflux pump inhibition assay,9 with cefotaxime and reser-
pine as the efflux pump inhibitor, indicated a lack of efflux 
pump-mediated resistance to cefotaxime.
As there existed the possibility of multiple genetic resis-
tance mechanisms in the clinical Salmonella Typhimurium 
isolate, we analyzed the isolate by whole genome sequenc-
ing. Whole genome sequencing of the isolate was performed 
by BGI Co., Ltd. (Shenzhen, People’s Republic of China) 
and Illumina (100×/sample, Hiseq 4000, PE100, San Diego, 
CA, USA). The “Phylogenomic Estimation with Progressive 
Refinement” program (https://github.com/enordber/pepr.
git) was used to generate a phylogenomic tree from in silico 
translated amino acid sequences using a maximum likelihood 
algorithm. The program identifies the common orthologues 
among genomes, filters for horizontally transferred genes, 
aligns and concatenates sequences, and finally generates a 
phylogenomic tree. Subtrees with low bootstrap values are 
refined by subsequent steps of addition local shared genes. 
The genome was annotated using the Rapid Annotation Using 
Subsystem Technology  program, a service present in the bio-
informatics resource center of the Pathosystems Resource Inte-
gration Center.10 Pathosystems Resource Integration Center’s 
“Specialty Genes Search” tool integrates different databases 
to identify virulence factors (VFDB, Victors and PATRIC 
VF), antibiotic resistance (ARDB and CARD), drug targets 
(DrugBank and TTD) and human homologs (Proteins from 
the Reference Human Genome at NCBI RefSeq). The tool 
was used to identify antibiotic resistance genes in the genome 
of our Salmonella Typhimurium isolate, which included the 
β-lactamase-encoding genes NDM-1, CMY-4, SHV-12, OXA-
9, and TEM1b. Several efflux pumps and outer membrane 
proteins associated with conferring resistance to antimicrobial 
drugs were identified. These comprised a type I secretion outer 
membrane protein, the TolC precursor, AcrA protein A and 
AcrB protein B, as well as a multidrug and toxin extrusion 
family efflux pump (Supplementary materials S1 and S2).
Discussion
Salmonella infections in burn patients are seldom reported 
except for an outbreak of Salmonella senftenburg.11 
β-lactamase production is the main mechanism associ-
ated with antibiotic resistance in Enterobacteriaceae, with 
ESBL and AmpC β-lactamase production being of particular 
importance. ESBL- and AmpC β-lactamase producers have 
not only been isolated from hospital settings, but are also 
disseminated in the environment, in animals, and in healthy 
humans.12 The prevalence of global CTX-M-type ESBLs 
exceeded TEM- and SHV-type enzymes in the early 2000s 
and plasmid-mediated AmpC β-lactamases of CIT-type 
are also currently widespread, both being major causes of 
β-lactam resistance.12
The advent of carbapenemase producing bacteria world-
wide, mainly NDM-1 and its variants in Enterobacteriaceae, 
has been a major public health concern. NDM-1 hydrolyzes 
even “last-resort” antibiotics that are used for treating infec-
tions caused by multidrug-resistant pathogens. That said, not 
only the expression of β-lactamases, but alteration in bacterial 
cell envelope porin expression, the production of penicillin-
binding proteins and the upregulation of efflux pumps are also 
known mechanisms responsible for carbapenem resistance 
among Enterobacteriaceae.6
Carbapenem resistance in Salmonella spp. is rarely 
reported. There are range of mechanisms by which Salmo-
nella spp. may acquire carbapenem resistance, including 
acquisition of carbapenemases such as KPC, NDM, IMP, 
VIM, and OXA.13 Carbapenem resistance due to the produc-
tion of extended-spectrum β-lactamases ESBLs or AmpC 
β-lactamases combined with porin loss has also been detected 
in nontyphoidal Salmonella.13,14 Huang et al,15 in 2013 iso-
lated a single community-acquired NDM-1-producing Sal-
monella Stanley strain from a child with acute diarrhea and a 
diagnosis of bacterial enteritis, which subsequently resolved 
after treatment with intravenous azithromycin and latamoxef 
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(an oxacephem antibiotic usually grouped with the cephalo-
sporins). This Salmonella Stanley strain was resistant to all 
β-lactam antimicrobial drugs tested, including cephalosporins 
and carbapenems, but susceptible to chloramphenicol, cipro-
floxacin, tetracycline, and fosfomycin, and had azithromycin 
MICs of 4 µg/mL.15 Irfan et al,16 in 2015 reported two cases 
of infantile diarrhea caused by MDR, NDM-1 producing, 
Salmonella Agona from Pakistan. In the first case, a stool 
culture grew carbapenem-resistant Salmonella spp., which 
was susceptible only to azithromycin, fosfomycin, and colis-
tin. Treatment with 250 mg oral fosfomycin (three times a 
day) improved the infant’s condition.16 NDM-1 and NDM-5 
producing S. enterica have been reported from many coun-
tries including the People’s Republic of China, Pakistan, and 
United Kingdom.15–17
Conclusion
In conclusion, we report the first case of a carbapenem-
resistant and MBL (NDM-1), ESBL (SHV-12), and AmpC 
β-lactamase (CMY-4) coproducing Salmonella Typhimurium 
isolated from a fatal case of burn wound infection. The 
publication highlights the necessity for the rational use of 
antibiotics (particularly the rational use of last-resort anti-
biotics such as carbapenems) in hospitals and burn units, as 
well as the need for systematic screening of Salmonella spp. 
(including S. enterica serovar Typhimurium) for resistance 
to carbapenem antibiotics.
Informed consent
All methods were carried out in accordance with relevant 
guidelines and regulations. The microbial isolate mentioned 
in this case report is cultured from sample collected during 
routine care and diagnostic investigations. The single patient 
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from whom it was isolated was deceased after collecting 
first sample. Written informed consent was obtained from 
the patient’s next of kin for the publication of this report.
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